InvestorsHub Logo
Followers 481
Posts 60468
Boards Moderated 18
Alias Born 09/20/2001

Re: None

Wednesday, 10/18/2017 4:36:21 PM

Wednesday, October 18, 2017 4:36:21 PM

Post# of 626
Biogen getting very aggressive about protecting their MS market -

Hoping for some new revelations soon..



New data from more than 80 oral and poster presentations, including research on potential predictive and digital biomarkers
Updates on real-world data generation initiatives, including MS PATHS, which leverages technology in routine care to produce real-time data, and the Big MS Data Network, intended to provide pooled registry data from more than 140,000 people living with
multiple sclerosis (MS)
Data supporting the Phase 2 investigational molecule opicinumab (anti-LINGO-1) as a potential therapy to repair damage to the central nervous system caused by MS



https://ih.advfn.com/p.php?pid=nmona&article=75886110



In Peace, In War

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIIB News